Elite Pharmaceuticals Inc
OTC:ELTP
Elite Pharmaceuticals Inc
OTC:ELTP
Price:
0.399
USD
-0.25%
Market Closed
Market Cap:
$428.7m
Balance Sheet
Balance Sheet Decomposition
Elite Pharmaceuticals Inc
Elite Pharmaceuticals Inc
Balance Sheet Decomposition is not available for
Elite Pharmaceuticals Inc
Elite Pharmaceuticals Inc
Balance Sheet
Elite Pharmaceuticals Inc
Elite Pharmaceuticals Inc
Currency: USD
| Mar-2002 | Mar-2003 | Mar-2004 | Mar-2005 | Mar-2006 | Mar-2007 | Mar-2008 | Mar-2009 | Mar-2010 | Mar-2011 | Mar-2012 | Mar-2013 | Mar-2014 | Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Cash & Cash Equivalents |
7
|
3
|
2
|
4
|
9
|
2
|
4
|
0
|
1
|
2
|
1
|
0
|
7
|
7
|
12
|
11
|
7
|
2
|
1
|
3
|
9
|
8
|
7
|
11
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
7
|
7
|
12
|
11
|
7
|
2
|
1
|
3
|
9
|
8
|
7
|
11
|
|
| Cash Equivalents |
7
|
3
|
2
|
4
|
9
|
2
|
4
|
0
|
1
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
1
|
1
|
2
|
1
|
1
|
1
|
4
|
3
|
3
|
3
|
19
|
29
|
|
| Accounts Receivables |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
1
|
1
|
2
|
1
|
1
|
1
|
4
|
3
|
3
|
3
|
19
|
29
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
1
|
1
|
0
|
1
|
2
|
3
|
3
|
6
|
5
|
5
|
4
|
5
|
7
|
10
|
13
|
16
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
1
|
1
|
1
|
1
|
|
| Total Current Assets |
8
|
4
|
3
|
5
|
11
|
3
|
6
|
2
|
2
|
3
|
2
|
3
|
10
|
12
|
17
|
18
|
14
|
9
|
10
|
12
|
19
|
22
|
40
|
58
|
|
| PP&E Net |
4
|
4
|
4
|
4
|
4
|
5
|
5
|
5
|
4
|
4
|
4
|
4
|
4
|
6
|
8
|
9
|
9
|
8
|
8
|
7
|
7
|
10
|
15
|
14
|
|
| PP&E Gross |
4
|
4
|
4
|
4
|
4
|
5
|
5
|
5
|
4
|
4
|
4
|
4
|
4
|
6
|
8
|
9
|
9
|
8
|
8
|
7
|
7
|
10
|
15
|
14
|
|
| Accumulated Depreciation |
1
|
1
|
1
|
2
|
2
|
2
|
3
|
3
|
4
|
4
|
5
|
5
|
6
|
6
|
7
|
7
|
8
|
10
|
11
|
12
|
13
|
15
|
16
|
17
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
6
|
6
|
6
|
6
|
8
|
7
|
7
|
7
|
7
|
6
|
6
|
6
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
1
|
1
|
1
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
3
|
23
|
19
|
|
| Total Assets |
13
N/A
|
9
-32%
|
8
-10%
|
9
+18%
|
16
+70%
|
10
-38%
|
15
+58%
|
11
-29%
|
11
-3%
|
12
+11%
|
10
-13%
|
11
+8%
|
24
+119%
|
26
+7%
|
32
+22%
|
34
+8%
|
31
-10%
|
24
-21%
|
25
+2%
|
26
+5%
|
35
+34%
|
41
+16%
|
84
+105%
|
96
+15%
|
|
| Liabilities | |||||||||||||||||||||||||
| Accounts Payable |
1
|
0
|
1
|
1
|
2
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
4
|
2
|
1
|
2
|
1
|
2
|
1
|
1
|
2
|
3
|
3
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
4
|
5
|
4
|
5
|
5
|
6
|
4
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
4
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
3
|
3
|
4
|
3
|
0
|
1
|
0
|
1
|
1
|
2
|
0
|
0
|
0
|
1
|
1
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
1
|
1
|
1
|
1
|
2
|
2
|
1
|
2
|
5
|
5
|
5
|
5
|
6
|
5
|
5
|
3
|
5
|
7
|
9
|
6
|
7
|
8
|
13
|
12
|
|
| Long-Term Debt |
3
|
3
|
3
|
2
|
4
|
4
|
4
|
3
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
3
|
3
|
2
|
2
|
1
|
4
|
5
|
4
|
|
| Other Liabilities |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
16
|
25
|
21
|
14
|
99
|
19
|
14
|
3
|
4
|
3
|
4
|
2
|
2
|
1
|
8
|
27
|
|
| Total Liabilities |
5
N/A
|
3
-28%
|
4
+17%
|
4
-7%
|
6
+68%
|
6
+4%
|
5
-23%
|
5
+5%
|
21
+326%
|
30
+40%
|
25
-15%
|
20
-22%
|
106
+433%
|
26
-76%
|
21
-20%
|
9
-58%
|
12
+43%
|
13
+5%
|
14
+10%
|
10
-30%
|
10
-1%
|
12
+20%
|
26
+118%
|
43
+64%
|
|
| Equity | |||||||||||||||||||||||||
| Common Stock |
12
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
1
|
36
|
1
|
1
|
15
|
15
|
15
|
1
|
1
|
1
|
1
|
1
|
|
| Retained Earnings |
24
|
29
|
35
|
41
|
50
|
63
|
81
|
90
|
101
|
115
|
130
|
128
|
225
|
144
|
143
|
139
|
143
|
152
|
154
|
149
|
140
|
136
|
116
|
121
|
|
| Additional Paid In Capital |
19
|
34
|
39
|
47
|
60
|
66
|
92
|
96
|
91
|
97
|
115
|
120
|
144
|
109
|
109
|
164
|
147
|
149
|
150
|
164
|
165
|
165
|
173
|
173
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
8
N/A
|
5
-33%
|
4
-25%
|
6
+41%
|
10
+71%
|
4
-64%
|
11
+201%
|
6
-44%
|
11
N/A
|
18
-69%
|
15
+16%
|
9
+42%
|
81
-837%
|
0
N/A
|
11
+4 052%
|
26
+130%
|
18
-28%
|
11
-38%
|
11
-6%
|
16
+52%
|
25
+56%
|
29
+15%
|
58
+99%
|
54
-7%
|
|
| Total Liabilities & Equity |
13
N/A
|
9
-32%
|
8
-10%
|
9
+18%
|
16
+70%
|
10
-38%
|
15
+58%
|
11
-29%
|
11
-3%
|
12
+11%
|
10
-13%
|
11
+8%
|
24
+119%
|
26
+7%
|
32
+22%
|
34
+8%
|
31
-10%
|
24
-21%
|
25
+2%
|
26
+5%
|
35
+34%
|
41
+16%
|
84
+105%
|
96
+15%
|
|
| Shares Outstanding | |||||||||||||||||||||||||
| Common Shares Outstanding |
10
|
10
|
12
|
18
|
19
|
21
|
23
|
61
|
84
|
181
|
332
|
374
|
560
|
631
|
711
|
928
|
803
|
825
|
840
|
1 009
|
1 011
|
1 014
|
1 068
|
1 068
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
